|
FOLD | Amicus Therapeutics, Inc. |
|
|
FOLD | Amicus Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.05 |
| Leverage | 73.48% |
| Market Cap | $ 4.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -14.5m |
| Margin | -2.37% |
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania.